Biotech

All Articles

Eisai plants molecular adhesive SEED along with $1.5 B biobucks deal

.Major Pharmas remain stuck to the concept of molecular adhesive degraders. The most recent firm to ...

Life science debt company unveils along with $600M

.A brand-new global lifestyle scientific research debt firm, called Symbiotic Funds, has increased m...

BMS channels TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing yet another big bet coming from the Caforio period, terminating a dea...

Nuvation stops wager prevention after looking at period 1 information

.After taking a look at period 1 data, Nuvation Bio has determined to stop work on its single top BD...

' Scientific intuition' led FDA consultants to support Zevra's unusual ailment med

.Zevra Therapeutics' unusual condition drug seems to be on the path to permission this loss after ob...

Pfizer takes $230M hit after axing stopped working DMD genetics treatment

.Pfizer's stage 3 Duchenne muscular dystrophy (DMD) genetics treatment failure has actually gone a $...

AC Immune sees 'site' potential in Alzheimer's drug records

.After more than twenty years of work on neurodegenerative illness, Swiss biotech a/c Invulnerable i...

GSK goes down ph. 2 HPV vaccine over shortage of best-in-class possible

.GSK has ditched a phase 2 individual papillomavirus (HPV) vaccine from its pipe after determining t...

OS Therapies refiles $6M IPO to finance HER2 medicine, preclinical ADCs

.Operating system Therapies will certainly detail on the NYSE American stock substitution this morni...

ALX's fizzling CD47 feedback cost delivers sell spiraling down

.ALX Oncology's phase 2 gastric cancer cells response price has actually damaged. After finding its ...